Management of Vestibular Schwannoma (Including NF2): Facial Nerve Considerations

Vivian Kaul; Maura K Cosetti

doi:10.1016/j.otc.2018.07.015

Management of Vestibular Schwannoma (Including NF2): Facial Nerve Considerations

Otolaryngol Clin North Am. 2018 Dec;51(6):1193-1212. doi: 10.1016/j.otc.2018.07.015.

Authors

Vivian Kaul¹, Maura K Cosetti²

Affiliations

¹ Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York Eye and Ear of Mount Sinai, Floor 6, 310 East 14th Street, New York, NY 10003, USA.
² Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York Eye and Ear of Mount Sinai, Floor 6, 310 East 14th Street, New York, NY 10003, USA. Electronic address: Maura.Cosetti@mountsinai.org.

PMID: 30390772
DOI: 10.1016/j.otc.2018.07.015

Abstract

Current consensus on optimal treatment of vestibular schwannoma remains poorly established; treatment options include observation, stereotactic radiosurgery, microsurgical resection, medical therapy, or a combination of these. Treatment should be individualized and incorporate the multitude of patient- and tumor-specific characteristics known to affect outcome. Treatment paradigms for sporadic and neurofibromatosis type 2-related tumors are distinct and decision-making in neurofibromatosis type 2 is uniquely challenging. In all cases, treatment should maximize tumor control and minimize functional deficit.

Keywords: Facial nerve; Facial paralysis; Intraoperative monitoring; Management; Vestibular schwannoma.

Publication types

Review

MeSH terms

Facial Nerve / surgery*
Hearing Loss / etiology
Humans
Microsurgery
Neuroma, Acoustic / physiopathology
Neuroma, Acoustic / therapy*
Plastic Surgery Procedures / methods*
Radiosurgery
Treatment Outcome